BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23101634)

  • 1. SnapShot: Bone Metastasis.
    Ell B; Kang Y
    Cell; 2012 Oct; 151(3):690-690.e1. PubMed ID: 23101634
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of bone metastasis.
    Roodman GD
    N Engl J Med; 2004 Apr; 350(16):1655-64. PubMed ID: 15084698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress in treatment of metastatic tumors in the bone by bisphosphonate].
    Dong M; Chen XP; Feng FY
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):801-3. PubMed ID: 18396633
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone metastases in breast cancer, prostate cancer and myeloma.
    Paterson AH
    Bone; 1987; 8 Suppl 1():S17-22. PubMed ID: 3318889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal treatment of metastatic bone cancer].
    Tubiana-Hulin M
    Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):821-7. PubMed ID: 2291074
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review.
    Chappard D; Bouvard B; Baslé MF; Legrand E; Audran M
    Morphologie; 2011 Jun; 95(309):65-75. PubMed ID: 21620753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines in bone diseases. Involvement of cytokines in bone metastasis].
    Takeuchi Y
    Clin Calcium; 2010 Oct; 20(10):1504-9. PubMed ID: 20890032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic bone disease: general principles, pathophysiology, evaluation, and biopsy.
    Frassica FJ; Gitelis S; Sim FH
    Instr Course Lect; 1992; 41():293-300. PubMed ID: 1588070
    [No Abstract]   [Full Text] [Related]  

  • 9. The bone remodeling environment is a factor in breast cancer bone metastasis.
    Ooi LL; Zheng Y; Stalgis-Bilinski K; Dunstan CR
    Bone; 2011 Jan; 48(1):66-70. PubMed ID: 20472107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of bone metastases].
    Tubiana-Hulin M
    Bull Cancer Radiother; 1996; 83(4):299-304. PubMed ID: 9081331
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor bone disease.
    Body JJ
    Ann Endocrinol (Paris); 2006 Apr; 67(2):166-72. PubMed ID: 16639371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P; Beuzeboc P
    Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonates in the therapy of cancer patients].
    Jantunen E; Kumpulainen E
    Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of radiation therapy for osseous metastasis].
    Watari T
    Nihon Seikeigeka Gakkai Zasshi; 1996 Oct; 70(10):659-72. PubMed ID: 8934461
    [No Abstract]   [Full Text] [Related]  

  • 16. How can we improve the treatment of bone metastases further?
    Coleman RE
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastases: Part I--Pathophysiology.
    Fisher G; Mayer DK; Struthers C
    Clin J Oncol Nurs; 1997 Apr; 1(2):29-35. PubMed ID: 9410649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Markers of bone tissue resorption in skeleton metastasis].
    Liubimova NV; Kushlinskiĭ NE; Robins SP
    Biull Eksp Biol Med; 1998 Mar; 125(3):323-8. PubMed ID: 9606556
    [No Abstract]   [Full Text] [Related]  

  • 19. Third North American Symposium on Skeletal Complications of Malignancy: summary of the scientific sessions.
    Mohla S; Weilbacher KN; Cher ML; Oyajobi BO; Poznak CV; Clohisy DR
    Cancer; 2003 Feb; 97(3 Suppl):719-25. PubMed ID: 12548568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
    Carducci MA; Jimeno A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6296s-6300s. PubMed ID: 17062717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.